- Home
- DVA vs GNRC Comparison
DVA vs GNRC Comparison
Compare DVA & GNRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DVA
- GNRC
- Stock Information
- Founded
- DVA 1994
- GNRC 1959
- Country
- DVA United States
- GNRC United States
- Employees
- DVA N/A
- GNRC N/A
- Industry
- DVA Misc Health and Biotechnology Services
- GNRC Metal Fabrications
- Sector
- DVA Health Care
- GNRC Consumer Discretionary
- Exchange
- DVA Nasdaq
- GNRC Nasdaq
- Market Cap
- DVA 9.4B
- GNRC 10.8B
- IPO Year
- DVA 1995
- GNRC 2010
- Fundamental
- Price
- DVA $126.99
- GNRC $194.99
- Analyst Decision
- DVA Hold
- GNRC Buy
- Analyst Count
- DVA 3
- GNRC 18
- Target Price
- DVA $151.00
- GNRC $185.56
- AVG Volume (30 Days)
- DVA 634.2K
- GNRC 1.1M
- Earning Date
- DVA 10-29-2025
- GNRC 10-29-2025
- Dividend Yield
- DVA N/A
- GNRC N/A
- EPS Growth
- DVA 8.72
- GNRC 54.62
- EPS
- DVA 10.20
- GNRC 6.03
- Revenue
- DVA $13,161,328,000.00
- GNRC $4,411,654,000.00
- Revenue This Year
- DVA $5.96
- GNRC $5.38
- Revenue Next Year
- DVA $3.54
- GNRC $8.33
- P/E Ratio
- DVA $12.35
- GNRC $31.58
- Revenue Growth
- DVA 5.09
- GNRC 9.69
- 52 Week Low
- DVA $122.93
- GNRC $99.50
- 52 Week High
- DVA $179.60
- GNRC $203.25
- Technical
- Relative Strength Index (RSI)
- DVA 43.91
- GNRC 68.63
- Support Level
- DVA $124.60
- GNRC $188.12
- Resistance Level
- DVA $127.92
- GNRC $196.50
- Average True Range (ATR)
- DVA 2.70
- GNRC 5.82
- MACD
- DVA -0.05
- GNRC 3.35
- Stochastic Oscillator
- DVA 33.99
- GNRC 92.89
About DVA DaVita Inc.
DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.
About GNRC Generac Holdlings Inc.
Generac designs and manufactures power generation equipment serving residential, commercial, and industrial markets. It offers standby generators, portable generators, lighting, outdoor power equipment, and a suite of clean energy products. Sales generated in the United States account for the majority of total sales.